UBS Group’s Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 RONI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-838
Closed -$1.23K 10288
2023
Q1
$1.23K Sell
838
-312
-27% -$427 ﹤0.01% 8778
2022
Q4
$1.44K Buy
+1,150
New +$520 ﹤0.01% 9870
2022
Q3
Sell
-1,599
Closed 11392
2022
Q2
$0 Sell
1,599
-4,908
-75% -$2.48K ﹤0.01% 11380
2022
Q1
$4K Buy
6,507
+4,355
+202% +$4.11K ﹤0.01% 9375
2021
Q4
$3K Buy
+2,152
New +$3.34K ﹤0.01% 9738

UBS Group's RONI.WS Position: Q2 2023 in Review

UBS Group sold out of Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (RONI.WS) in Q2 2023, closing a stake of 838 shares — an estimated $1.23K sold.

UBS Group first reported a position in RONI.WS in Q4 2021 and held it in 5 quarters. The position peaked at $4K in Q1 2022. 0 funds tracked by Wall St. Rank hold RONI.WS as of Q2 2023.

  • UBS Group reported no remaining Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 838 Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $1.23K.
  • UBS Group first reported a position in Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 5 quarters.
  • UBS Group's Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $4K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.